隐性隐球菌抗原阳性者氟康唑抢先治疗后隐球菌相关死亡仍高
该队列研究纳入南非约翰内斯堡两家医院CD4<100个/µL的HIV感染者,按1:2比较无症状CrAg阳性与阴性者6个月内的死亡原因。CrAg阳性者死亡率25%,阴性者9%,校正CD4后死亡风险比为3.0;隐球菌病是阳性者死亡的主因,尸检发现部分患者脑脊液CrAg筛查时阴性。
要点
- 无症状CrAg阳性且CD4<100个/µL的HIV患者6个月死亡率达25%,显著高于CrAg阴性者的9%。
- 隐球菌病是CrAg阳性者死亡的主要直接或促因,占死亡者的71%。
- 脑脊液CrAg筛查阴性不能排除隐球菌病,尸检发现脑膜和肺部隐球菌感染。
核心结论
- 尽管对无症状CrAg阳性者进行腰椎穿刺筛查并给予氟康唑抢先治疗,隐球菌病仍是该人群死亡的重要原因。
研究设计与样本
- 前瞻性队列研究,纳入CD4<100个/µL的HIV感染者,无症状CrAg阳性67例与CrAg阴性134例按1:2比例入组,随访6个月,死亡者尽可能行微创尸检。
主要发现
- CrAg阳性死亡者中12/17(71%)的隐球菌病为直接或促因。
- 4例CrAg阳性死亡者尸检均发现隐球菌性脑膜炎和肺隐球菌病,其中3例在筛查时腰椎穿刺脑脊液CrAg阴性。
临床怎么用
- 对CD4<100个/µL的HIV感染者应筛查CrAg,阳性者需腰椎穿刺和血培养全面评估隐球菌病。
- CrAg阳性者应尽早启动抗逆转录病毒治疗,并考虑更强效的抗真菌方案以降低死亡率。
局限性
- 仅纳入两家医院就诊患者,样本量有限,微创尸检仅在部分死亡者中完成。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cryptococcal antigen (CrAg) screening and treatment with preemptive fluconazole reduces the incidence of clinically evident cryptococcal meningitis in individuals living with advanced human immunodeficiency virus (HIV) disease. However, mortality remains higher in CrAg-positive than in CrAg-negative patients with similar CD4+ T-lymphocyte counts. METHODS: We conducted a cohort study to investigate causes of morbidity and mortality during 6 months of follow-up among asymptomatic CrAg-positive and CrAg-negative (ratio of 1:2) patients living with HIV with CD4 counts <100 cells/µL attending 2 hospitals in Johannesburg, South Africa. When possible, minimally invasive autopsy (MIA) was performed on participants who died. RESULTS: Sixty-seven CrAg-positive and 134 CrAg-negative patients were enrolled. Death occurred in 17/67 (25%) CrAg-positive and 12/134 (9%) CrAg-negative participants (hazard ratio for death, adjusted for CD4 count, 3.0; 95% confidence interval, 1.4-6.7; P = .006). Cryptococcal disease was an immediate or contributing cause of death in 12/17 (71%) CrAg-positive participants. Postmortem cryptococcal meningitis and pulmonary cryptococcosis were identified at MIA in all 4 CrAg-positive participants, 3 of whom had negative cerebrospinal fluid CrAg tests from lumbar punctures (LPs) at the time of CrAg screening. CONCLUSIONS: Cryptococcal disease was an important cause of mortality among asymptomatic CrAg-positive participants despite LPs to identify and treat those with subclinical cryptococcal meningitis and preemptive fluconazole for those without meningitis. Thorough investigation for cryptococcal disease with LPs and blood cultures, prompt ART initiation, and more intensive antifungals may reduce mortality among asymptomatic CrAg-positive patients identified through screening.
引用
- Wake RM, Govender NP, Omar T, et al. Cryptococcal-related Mortality Despite Fluconazole Preemptive Treatment in a Cryptococcal Antigen Screen-and-Treat Program. Clin Infect Dis. 2020. PMID: 31179488. doi:10.1093/cid/ciz485
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。